ATE477797T1 - Zusammensetzung enthaltend magnolol und honokiol in synergistischen mengen - Google Patents

Zusammensetzung enthaltend magnolol und honokiol in synergistischen mengen

Info

Publication number
ATE477797T1
ATE477797T1 AT08171088T AT08171088T ATE477797T1 AT E477797 T1 ATE477797 T1 AT E477797T1 AT 08171088 T AT08171088 T AT 08171088T AT 08171088 T AT08171088 T AT 08171088T AT E477797 T1 ATE477797 T1 AT E477797T1
Authority
AT
Austria
Prior art keywords
honokiol
composition containing
magnolol
synergistic amounts
containing magnolol
Prior art date
Application number
AT08171088T
Other languages
English (en)
Inventor
Claus Kilpert
Daniel Raederstorff
Nathalie Richard
Joseph Schwager
Karin Wertz
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Application granted granted Critical
Publication of ATE477797T1 publication Critical patent/ATE477797T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A61K36/575—Magnolia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT08171088T 2007-12-11 2008-12-09 Zusammensetzung enthaltend magnolol und honokiol in synergistischen mengen ATE477797T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07023983 2007-12-11
EP07023947 2007-12-11

Publications (1)

Publication Number Publication Date
ATE477797T1 true ATE477797T1 (de) 2010-09-15

Family

ID=40433904

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08171088T ATE477797T1 (de) 2007-12-11 2008-12-09 Zusammensetzung enthaltend magnolol und honokiol in synergistischen mengen

Country Status (4)

Country Link
US (1) US20090156551A1 (de)
EP (1) EP2070523B1 (de)
AT (1) ATE477797T1 (de)
DE (1) DE602008002206D1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT518206A2 (de) * 2016-01-29 2017-08-15 Neovia Proteinkinase-C-Inhibitor enthaltender Tierfutterzusatz
WO2019121319A1 (en) 2017-12-22 2019-06-27 Unilever N.V. An antimicrobial composition
US20200330408A1 (en) 2017-12-22 2020-10-22 Conopco, Inc., D/B/A Unilever An antimicrobial composition
US12311044B2 (en) 2018-12-18 2025-05-27 Conopco, Inc. Antimicrobial composition
CN114181409B (zh) * 2021-12-31 2023-12-12 贵州省化工研究院 油茶籽壳纳米纤维素基高内相Pickering乳液及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294170B1 (en) * 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
US20040105906A1 (en) * 2002-03-22 2004-06-03 Arbiser Jack L. Antiagionecic, antitumor, chemopreventative agents
US20040048910A1 (en) * 2002-08-22 2004-03-11 Bove Susan Elizabeth Method of treating osteoarthritis
WO2004092132A1 (en) * 2003-04-15 2004-10-28 Warner-Lambert Company Llc [b]-fused bicyclic proline derivatives and their use for treating arthritic conditions
US20060074108A1 (en) * 2004-10-04 2006-04-06 Bioderm Research Matrix metalloprotease (MMP) inhibitors and their application in cosmetic and pharmaceutical composition
US8900644B2 (en) * 2004-12-22 2014-12-02 Colgate-Palmolive Company Oral care compositions containing compounds from magnolia and hops extracts
US20060140885A1 (en) * 2004-12-29 2006-06-29 Abdul Gaffar Method of reducing oral tissue inflammation using magnolia extract
US7776915B2 (en) * 2005-03-24 2010-08-17 Tracie Martyn International, Llc Topical formulations and methods of use
EP2049134A2 (de) * 2006-07-14 2009-04-22 DSMIP Assets B.V. Zusammensetzungen mit hagebutte und anderen wirkstoffen zur behandlung von entzündlichen erkrankungen
WO2008006582A1 (en) * 2006-07-14 2008-01-17 Dsm Ip Assets B.V. Compositions comprising magnolol or honokiol and other active agents for the treatment of inflammatory diseases
JP5339373B2 (ja) * 2006-07-14 2013-11-13 ディーエスエム アイピー アセッツ ビー．ブイ． 組成物および炎症障害の治療、共治療または予防のためのその使用

Also Published As

Publication number Publication date
US20090156551A1 (en) 2009-06-18
EP2070523B1 (de) 2010-08-18
DE602008002206D1 (de) 2010-09-30
EP2070523A1 (de) 2009-06-17

Similar Documents

Publication Publication Date Title
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
IN2012DN01233A (de)
EA201200968A1 (ru) Применение транс-кломифена для предотвращения или лечения диабета 2 типа у мужчин
CO6690805A2 (es) 6-amino-nicotinamidas sustituidas como modulares de kcnq2/3
BRPI0619153B8 (pt) derivados de 4-amino-pirroltriazina substituída, e composição farmacêutica
UA107783C2 (en) Isoindoline compounds for use in treating cancer
EA200970542A1 (ru) ИНГИБИТОРЫ ДЕЙСТВИЯ Akt
WO2006107451A3 (en) Honokiol derivatives for the treatment of proliferative disorders
MX2011011486A (es) Composiciones orales que contienen compuestos de poliguandino y metodos de preparacion y uso de las mismas.
MA32776B1 (fr) Inhibiteurs de l'akt et de la p70 s6 kinase
SE0403006D0 (sv) New compounds
ATE477797T1 (de) Zusammensetzung enthaltend magnolol und honokiol in synergistischen mengen
CY1115384T1 (el) Αντι-φλεγμονωδης συνθεση
SG158091A1 (en) Imidazoazepinone compounds
ATE522500T1 (de) Amidderivate als ionenkanalliganden sowie pharmazeutische zusammensetzungen und verwendungsverfahren dafür
ECSP13012453A (es) 2-oxi-quinolina-3-carboxamidas sustituidas como moduladores KCNQ2/3
EA201400660A1 (ru) Противомикробная композиция
EA025162B9 (ru) Противомикробная композиция
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
UA89201C2 (ru) Энантиомеры выбранных конденсированных пиримидонов и их применение для лечения и профилактики злокачественного новообразования
ATE474574T1 (de) Imidazoazephinonverbindungen
BR112013033438A2 (pt) dha e epa na redução do estresse oxidativo
MX342459B (es) 2-oxo- y 2-tioxo-dihidroquinolin-3-carboxamidas sustituidas, como moduladores de kcnq2/3.
GB0514811D0 (en) Compounds
MX2013002295A (es) 1-oxo-dihidroisoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties